Listen The fate of BristolMyersCelgene the tragedy of SIDS and health techs unforeseen challenge

Listen: The fate of Bristol-Myers-Celgene, the tragedy of SIDS, and health tech’s unforeseen challenge

In the latest episode of our #biotech #podcast, "The Readout LOUD," we dig into the potential $BMY $CELG merger and an unforeseen challenge that many #digitalhealth startups are facing. Listen…

More From BioPortfolio on "Listen: The fate of Bristol-Myers-Celgene, the tragedy of SIDS, and health tech’s unforeseen challenge"